Literature DB >> 11797607

Detection of galactomannan for diagnosis of fungal rhinosinusitis.

C Kauffmann-Lacroix, M H Rodier, J L Jacquemin, J M Goujon, J M Klossek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11797607      PMCID： PMC88599          DOI： 10.1128/JCM.39.12.4593-4594.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  6 in total

Review 1.  Definitions of fungal rhinosinusitis.

Authors:  B J Ferguson
Journal:  Otolaryngol Clin North Am       Date:  2000-04       Impact factor: 3.346

2.  A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis.

Authors:  D Stynen; A Goris; J Sarfati; J P Latgé
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

3.  Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients.

Authors:  P E Verweij; D Stynen; A J Rijs; B E de Pauw; J A Hoogkamp-Korstanje; J F Meis
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

4.  [Measurement of agreement between 2 judges. Qualitative cases].

Authors:  J Fermanian
Journal:  Rev Epidemiol Sante Publique       Date:  1984       Impact factor: 1.019

5.  Functional endoscopic sinus surgery and 109 mycetomas of paranasal sinuses.

Authors:  J M Klossek; E Serrano; L Péloquin; J Percodani; J P Fontanel; J J Pessey
Journal:  Laryngoscope       Date:  1997-01       Impact factor: 3.325

6.  Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus.

Authors:  J P Latgé; H Kobayashi; J P Debeaupuis; M Diaquin; J Sarfati; J M Wieruszeski; E Parra; J P Bouchara; B Fournet
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441
  6 in total
  1 in total

Review 1.  Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis.

Authors:  Laura L Kovanda; Amit V Desai; William W Hope
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-08       Impact factor: 2.745
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.